Latest SNM Stories
Maximizing quality in clinical trials is emphasized at this year's gathering of experts from molecular imaging centers, biomarker manufacturers, regulatory agencies and the pharmaceutical industry.
SNM and a coalition of eight other organizations have issued a white paper urging Congress to take steps to maintain adequate supplies of Molybdenum-99 (Mo-99), a radioactive substance that is the basis for a common medical isotope used in more than 80 percent of all nuclear medicine procedures.
By Anonymous SNM and SNMTS introduced their 2008-2009 slates of officers at the 55th Annual Meeting, held June 14-18 in New Orleans, LA. During their tenure, SNM officers will work with membership to advance initiatives around nuclear medicine and molecular imaging research and therapies.
RESTON, Va., July 17 /PRNewswire-USNewswire/ -- SNM, an international scientific and professional organization of more than 16,000 members, applauds Congress for overriding the presidential veto of the Medicare Improvements for Patients and Providers Act of 2008.
By Conti, Peter S McEwan, Alexander J B; Pomper, Martin G The second Industry/Expert Molecular Imaging Summit, "Molecular Imaging: The Future of Modern Medicine," was held February 17-19 in Newport Beach, CA.